Follow The Filings

GANX Gain Therapeutics

Gain Therapeutics earnings company data as of 11:21 PM ET 11/17

  • 1 of 1 EPS beats

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 10 Nov EPS -0.13 -0.07 Beat
Rev — — —

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 8.01
10-Q
8-K 2.02,9.01
8-K 5.02,9.01
8-K 8.01
8-K 5.02
8-K 2.02,9.01
10-Q
8-K 8.01
8-K 8.01
8-K 5.07
8-K 8.01
8-K 2.02,9.01
10-Q
DEF 14A
DEFA14A
8-K 2.02,9.01
10-K
8-K 7.01,8.01,9.01
8-K 7.01,9.01
8-K 8.01
424B5
8-K 8.01,9.01
8-K 2.02,9.01
10-Q

Insider forms

Forms 3, 4 and 5 from EDGAR, 2 rows shown

Filed Form Detail Links
4 Period Oct 29, 2026
4 Period Jul 15, 2026 (4 forms)

4 more insider forms

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf